In parallel, AGEs’ effects seem to also relate to platelet activating factor (PAF) levels [35], which, in turn, are implicated in cardiovascular disease [36] and metabolic abnormalities [37]. This evidence concerns the gene PCLAF and cardiovascular disorder.